The brain's aging immune system

Aging and Disease

Volumn 1, Issue 3, 2010, Pages 254-261

  Streit, Wolfgang J ^a   Xue, Qing Shan ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Aging; Immune system; Immunosenescence; Neurofibrillary degeneration

Indexed keywords

RODENTIA;

EID: 84862308462     PISSN: None     EISSN: 21525250     Source Type: Journal    
DOI: None     Document Type: Review

References (44)

1. Streit WJ (2010). Microglial activation and neuroinflammation in Alzheimer's disease: a critical examination of recent history. Front Aging Neurosci 2: 22.
2. Streit WJ (2004). Microglia and Alzheimer's disease pathogenesis. J Neurosci Res 77: 1-8.
3. Nakajima K, Kohsaka S (2004). Microglia: neuroprotective and neurotrophic cells in the central nervous system. Curr Drug Targets Cardiovasc Haematol Disord 4: 65-84.
4. Streit WJ (2002). Microglia as neuroprotective, immunocompetent cells of the CNS. Glia 40: 133-139.
5. Streit WJ (2005). Microglia and neuroprotection: implications for Alzheimer's disease. Brain Res Brain Res Rev 48: 234-239.
6. Streit WJ (2006). Microglial senescence: does the brain's immune system have an expiration date? Trends Neurosci 29: 506-510.
7. Banati RB, Graeber MB (1994). Surveillance, intervention and cytotoxicity: is there a protective role of microglia? Dev Neurosci 16: 114-127.
8. Vaughan DW, Peters A (1974). Neuroglial cells in the cerebral cortex of rats from young adulthood to old age: an electron microscope study. J Neurocytol 3: 405-429.
9. Samorajski T (1976). How the human brain responds to aging. J Am Geriatr Soc 24: 4-11.
10. Perry VH, Matyszak MK, Fearn S (1993). Altered antigen expression of microglia in the aged rodent CNS. Glia 7: 60-67.
11. Ogura K, Ogawa M, Yoshida M (1994). Effects of ageing on microglia in the normal rat brain: immunohistochemical observations. Neuroreport 5: 1224-1226.
12. Sheffield LG, Berman NE (1998). Microglial expression of MHC class II increases in normal aging of nonhuman primates. Neurobiol Aging 19: 47-55.
13. Conde JR, Streit WJ (2006). Effect of aging on the microglial response to peripheral nerve injury. Neurobiol Aging 27: 1451-1461.
14. Kreutzberg GW (1968).[Autoradiographic studies on perineuronal microgliocytes]. Acta Neuropathol (Berl): Suppl 4:141-145.
15. Ladeby R, Wirenfeldt M, Dalmau I, Gregersen R, Garcia-Ovejero D, et al. (2005). Proliferating resident microglia express the stem cell antigen CD34 in response to acute neural injury. Glia 50: 121-131.
16. Lawson LJ, Perry VH, Gordon S (1992). Turnover of resident microglia in the normal adult mouse brain. Neuroscience 48: 405-415.
17. Svensson M, Mattsson P, Aldskogius H (1994). A bromodeoxyuridine labelling study of proliferating cells in the brainstem following hypoglossal nerve transection. J Anat 185 (Pt 3): 537-542.
18. Hayflick L, Moorhead PS (1961). The serial cultivation of human diploid cell strains. Exp Cell Res 25: 585-621.
19. Olovnikov AM (1971). [Principle of marginotomy in template synthesis of polynucleotides]. Dokl Akad Nauk SSSR 201: 1496-1499.
20. Greider CW, Blackburn EH (1985). Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 43: 405-413.
21. Flanary BE, Streit WJ (2004). Progressive telomere shortening occurs in cultured rat microglia, but not astrocytes. Glia 45: 75-88.
22. Hochberg FH, Miller DC (1988). Primary central nervous system lymphoma. J Neurosurg 68: 835-853.
23. Miller KR, Streit WJ (2007). The effects of aging, injury and disease on microglial function: a case for cellular senescence. Neuron Glia Biol 3: 245-253.
24. Sierra A, Gottfried-Blackmore AC, McEwen BS, Bulloch K (2007). Microglia derived from aging mice exhibit an altered inflammatory profile. Glia 55: 412-424.
25. Xie Z, Morgan TE, Rozovsky I, Finch CE (2003). Aging and glial responses to lipopolysaccharide in vitro: greater induction of IL-1 and IL-6, but smaller induction of neurotoxicity. Exp Neurol 182: 135-141.
26. Ye SM, Johnson RW (1999). Increased interleukin-6 expression by microglia from brain of aged mice. J Neuroimmunol 93: 139-148.
27. Njie EG, Boelen E, Stassen FR, Steinbusch HW, Borchelt DR, et al (2010). Ex vivo cultures of microglia from young and aged rodent brain reveal age-related changes in microglial function. Neurobiol Aging, [Epub ahead of print]
28. Ye SM, Johnson RW (2001). An age-related decline in interleukin-10 may contribute to the increased expression of interleukin-6 in brain of aged mice. Neuroimmunomodulation 9: 183-192.
29. Godbout JP, Johnson RW (2004). Interleukin-6 in the aging brain. J Neuroimmunol 147: 141-144.
30. Wolvekamp MC, Marquet RL (1990). Interleukin-6: historical background, genetics and biological significance. Immunol Lett 24: 1-9.
31. Streit WJ, Hurley SD, McGraw TS, Semple-Rowland SL (2000). Comparative evaluation of cytokine profiles and reactive gliosis supports a critical role for interleukin-6 in neuron-glia signaling during regeneration. J Neurosci Res 61: 10-20.
32. Kiefer R, Lindholm D, Kreutzberg GW (1993). Interleukin-6 and transforming growth factor-beta 1 mRNAs are induced in rat facial nucleus following motoneuron axotomy. Eur J Neurosci 5: 775-781.
33. Klein MA, Moller JC, Jones LL, Bluethmann H, Kreutzberg GW, et al. (1997). Impaired neuroglial activation in interleukin-6 deficient mice. Glia 19: 227-233.
34. Fattori E, Lazzaro D, Musiani P, Modesti A, Alonzi T, et al. (1995). IL-6 expression in neurons of transgenic mice causes reactive astrocytosis and increase in ramified microglial cells but no neuronal damage. Eur J Neurosci 7: 2441-2449.
35. Chakrabarty P, Jansen-West K, Beccard A, Ceballos-Diaz C, Levites Y, et al. Massive gliosis induced by interleukin-6 suppresses Abeta deposition in vivo: evidence against inflammation as a driving force for amyloid deposition. FASEB J 24: 548-559.
36. Streit WJ, Sammons NW, Kuhns AJ, Sparks DL (2004). Dystrophic microglia in the aging human brain. Glia 45: 208-212.
37. Streit WJ, Braak H, Xue QS, Bechmann I (2009). Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease. Acta Neuropathol 118: 475-485.
38. Hasegawa-Ishii S, Takei S, Chiba Y, Furukawa A, Umegaki H, et al (2010). Morphological impairments in microglia precede age-related neuronal degeneration in senescence-accelerated mice. Neuropathology, [Epub ahead of print].
39. Kawamata T, Akiguchi I, Maeda K, Tanaka C, Higuchi K, et al. (1998). Age-related changes in the brains of senescence-accelerated mice (SAM): association with glial and endothelial reactions. Microsc Res Tech 43: 59-67.
40. Geerts H (2009). Of mice and men: bridging the translational disconnect in CNS drug discovery. CNS Drugs 23: 915-926.
41. Fiala M, Lin J, Ringman J, Kermani-Arab V, Tsao G, et al. (2005). Ineffective phagocytosis of amyloid-beta by macrophages of Alzheimer's disease patients. J Alzheimers Dis 7: 221-232.
42. Floden AM, Combs CK (2006) Beta-amyloid stimulates murine postnatal and adult microglia cultures in a unique manner. J Neurosci 26: 4644-4648.
43. Panossian LA, Porter VR, Valenzuela HF, Zhu X, Reback E, et al. (2003). Telomere shortening in T cells correlates with Alzheimer's disease status. Neurobiol Aging 24: 77-84.
44. McRae A, Martins RN, Fonte J, Kraftsik R, Hirt L, et al. (2007). Cerebrospinal fluid antimicroglial antibodies in Alzheimer disease: a putative marker of an ongoing inflammatory process. Exp Gerontol 42: 355-363.